Alumis Corporate Presentation - May 2026 3.7 MB Envudeucitinib ONWARD1 and ONWARD2 Phase 3 Data Presentation 2.7 MB Alumis Envudeucitinib ONWARD Phase 3 Plaque Psoriasis Trial Results Event Presentation 901.2 KB
